Insider Transactions in Q1 2021 at Alector, Inc. (ALEC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,800
-6.07%
|
$303,600
$22.21 P/Share
|
|
Mar 23
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+5.72%
|
$110,400
$8.16 P/Share
|
|
Mar 22
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-6.28%
|
$690,000
$23.2 P/Share
|
|
Mar 22
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+10.96%
|
$240,000
$8.16 P/Share
|
|
Mar 09
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,175
-8.23%
|
$345,150
$18.12 P/Share
|
|
Mar 09
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,175
+3.89%
|
$172,575
$9.15 P/Share
|
|
Feb 09
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,175
-8.23%
|
$383,500
$20.81 P/Share
|
|
Feb 09
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,175
+3.89%
|
$172,575
$9.15 P/Share
|
|
Jan 26
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
27,308
-11.33%
|
$491,544
$18.0 P/Share
|
|
Jan 26
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,308
+5.3%
|
$245,772
$9.15 P/Share
|
|
Jan 25
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-12.31%
|
$540,000
$18.01 P/Share
|
|
Jan 25
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.6%
|
$270,000
$9.15 P/Share
|
|
Jan 20
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,567
-3.85%
|
$154,206
$18.0 P/Share
|
|
Jan 20
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,567
+1.89%
|
$77,103
$9.15 P/Share
|
|
Jan 19
2021
|
Robert Paul Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-12.31%
|
$540,000
$18.12 P/Share
|
|
Jan 19
2021
|
Robert Paul Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.6%
|
$270,000
$9.15 P/Share
|